Valuation: Elekta AB (publ)

Market Cap 1.95TCr 200.88Cr 173.08Cr 163.88Cr 148.54Cr 278.67Cr 19TCr 280.09Cr 748.48Cr 9.76TCr 754.43Cr 737.87Cr 31TCr P/E 2027 *
12.4x
P/E 2028 * 11.4x
Enterprise Value 2.29TCr 235.97Cr 203.31Cr 192.51Cr 174.49Cr 327.36Cr 23TCr 329.02Cr 879.24Cr 11TCr 886.22Cr 866.78Cr 36TCr EV / Sales 2027 *
1.32x
EV / Sales 2028 * 1.23x
Free-Float
94.03%
Yield 2027 *
5%
Yield 2028 * 5.61%
Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 200.88Cr
-0.24%+0.73%+28.02%+17.80% 23TCr
+0.15%-2.55%+6.07%-21.10% 14TCr
+1.38%+6.50%-14.07%+22.78% 13TCr
+4.27%-0.49%-55.18%-15.42% 6.23TCr
+2.17%+1.37%-18.11%-13.58% 4.94TCr
+1.67%-1.29%+12.56%+15.64% 4.86TCr
-1.16%-1.23%+15.45%+26.26% 4.14TCr
-0.77%+0.31%+35.15%+48.58% 4.01TCr
+1.62%+0.34%-18.21%+50.23% 3.12TCr
Average +0.91%-3.23%-0.92%+14.58% 8.55TCr
Weighted average by Cap. +0.63%-2.40%+4.03%+10.07%

Financials

2027 *2028 *
Net sales 1.73TCr 178.94Cr 154.17Cr 145.98Cr 132.32Cr 248.23Cr 17TCr 249.49Cr 666.72Cr 8.7TCr 672.02Cr 657.27Cr 27TCr 1.81TCr 186.78Cr 160.93Cr 152.38Cr 138.12Cr 259.12Cr 18TCr 260.43Cr 695.95Cr 9.08TCr 701.47Cr 686.08Cr 29TCr
Net income 151.21Cr 16Cr 13Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 58Cr 758.5Cr 59Cr 57Cr 2.4TCr 163.88Cr 17Cr 15Cr 14Cr 13Cr 23Cr 1.62TCr 24Cr 63Cr 822.07Cr 64Cr 62Cr 2.6TCr
Net Debt 340.03Cr 35Cr 30Cr 29Cr 26Cr 49Cr 3.35TCr 49Cr 130.76Cr 1.71TCr 131.8Cr 128.9Cr 5.39TCr 287.88Cr 30Cr 26Cr 24Cr 22Cr 41Cr 2.84TCr 41Cr 110.7Cr 1.44TCr 111.58Cr 109.13Cr 4.56TCr
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!